Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol

British Journal of Haematology

Volumn 163, Issue 4, 2013, Pages 458-464

  Poch Martell, Marc ^a   Atenafu, Eshetu G ^a   Minden, Mark D ^a   Schuh, Andre C ^a   Yee, Karen W L ^a   Schimmer, Aaron D ^a   Gupta, Vikas ^a   Brandwein, Joseph M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy; Elderly; Leukaemia

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COTRIMOXAZOLE; CYTARABINE PLUS HYDROCORTISONE PLUS METHOTREXATE; DEXAMETHASONE; DOXORUBICIN; ENOXAPARIN; FLUCONAZOLE; IMATINIB; METHOTREXATE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BACTEREMIA; BCR ABL1 GENE; BONE MARROW EXAMINATION; BRAIN ABSCESS; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONSTIPATION; CONTROLLED STUDY; CYTOGENETICS; CYTOPENIA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ENTEROCOLITIS; FEBRILE NEUTROPENIA; FEMALE; GASTRITIS; GENE REARRANGEMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERGLYCEMIA; IMMUNOPHENOTYPING; LIVER TOXICITY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYOPATHY; NEUROPATHY; ONCOGENE; OSTEOPENIA; OVERALL SURVIVAL; PANCREATITIS; PERIPHERAL EDEMA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; SIDE EFFECT; SUBDURAL HEMATOMA; TUMOR LYSIS SYNDROME; VEIN THROMBOSIS;

ACUTE LYMPHOBLASTIC LEUKAEMIA; CHEMOTHERAPY; ELDERLY; LEUKAEMIA;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84886378838     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12561     Document Type: Article

References (21)

1. Barry, E., DeAngelo, D.J., Neuberg, D., Stevenson, K., Loh, M.L., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M., Cohen, H.J., Sallan, S.E. & Silvermen, L.B. (2007) Favourable outcome for adolescents with acute lymphoblastic leukemia treated on Dana Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols. Journal of Clinical Oncology, 25, 813-819.
2. Bassan, R., Rossi, G., Pogliani, E.M., Di Bona, E., Angelucci, E., Cavattoni, I., Lambertenghi-Delilers, G., Mannelli, F., Levis, A., Ciceri, F., Mattei, D., Borlenghi, E., Terruzzi, E., Borghero, C., Romani, C., Spinelli, O., Tosi, M., Oldani, E., Intermesoli, T. & Rambaldi, A. (2010) Chemotherapy-Phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group Protocol 09/00. Journal of Clinical Oncology, 28, 3644-3652.
3. Brandwein, J.M., Gupta, V., Wells, R.A., Schuh, A.C., Schimmer, A.D., Lipton, J.H., Messner, H.A., Yi, Q., Chun, K., Kamel-Reid, S. & Minden, M.D. (2005) Treatment of elderly patients with acute lymphoblastic leukemia - Evidence for a benefit of imatinib in BCR-ABL positive patients. Leukemia Research, 29, 1381-1386.
4. Daenen, S., van der Holt, B., Dekker, A.W., Willemse, R., Rijneveld, A.W., Biemond, B.J., Muus, P., van de Loosdrecht, A.A., Schouten, H.C., van Marwijk Kooy, M., Breems, D.A., Demuynck, H., Maertens, J., Wijermans, P.W., Wittebol, S., de Klerk, E.W. & Cornelissen, J.J. (2012) Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. Leukemia, 26, 1726-1729.
5. Extermann, M. & Wedding, U. (2012) Co-morbidity and geriatric assessment for older patients with hematologic malignancies: a review of the evidence. Journal of Geriatric Oncology, 3, 49-57.
6. Fielding, A. (2011) Current therapeutic strategies in adult acute lymphoblastic leukemia. Hematology/Oncology Clinics of North America, 25, 1255-1279.
7. Gupta, V., Chun, K., Qi-Long, Y., Minden, M., Schuh, A., Wells, R.A. & Brandwein, J. (2005) Disease biology rather than age is the most important determinant of survival of AML patients ≥60 years treated with uniform intensive therapy. Cancer, 103, 2082-2090.
8. Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., Vernant, J.P., Lafage-Pochitaloff, M., Chassevent, A., Lheritier, V., Macintyre, E., Bene, M.C., Ifrah, N. & Dombret, H. (2009) Pediatric inspired therapy in adults with Philadelphia chromosome negative acute lymphoblastic leukemia: the GRAALL 2003 study. Journal of Clinical Oncology, 27, 911-918.
9. Kantarjian, H., Thomas, D., Jorgensen, J., Jabbour, E., Kebriaei, P., Rytting, M., York, S., Ravandi, F., Kwari, M., Faderl, S., Rios, M.B., Cortes, H., Fayad, L., Tarnai, R., Wang, S.A., Champlin, R., Advani, A. & O'Brien, S. (2012) Inotuzumab ozogamicin, an anti-CD22-caleacheamycin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. Lancet Oncology, 13, 403-411.
10. de Labarthe, A., Rousselot, P., Huguet-Rigal, F., Delabesse, E., Witz, F., Maury, S., Rea, D., Cayuela, J.M., Vekemans, M.C., Reman, O., Buzyn, A., Pigneau, A., Escoffre, M., Calandon, Y., MacIntyre, E., Lheritier, V., Vernant, J.P., Thomas, X., Ifrah, N. & Dombret, H. (2007) Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood, 109, 1408-1413.
11. O'Brien, S., Thomas, D., Ravandi, F., Faderl, S., Pierce, S. & Kantarjian, H. (2008) Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia. Cancer, 113, 2097-2101.
12. Ottmann, O.G., Wassmann, B., Pfeifer, H., Giagounidis, A., Stelljes, M., Duhrsen, U., Schmalzing, M., Wunderle, L., Binckebanck, A. & Hoelzer, D. (2007) Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer, 109, 2068-2076.
13. Pagano, L., Mele, L. & Trape Leone, G. (2004) The treatment of acute lymphoblastic leukemia in the elderly. Leukemia & Lymphoma, 45, 117-123.
14. Ribera, J.M. (2011) Advances in acute lymphoblastic leukemia. Current Opinion in Oncology, 23, 692-699.
15. Sancho, J.M., Ribera, J.M., Xicoy, B., Morgades, M., Oriol, A., Tormo, M., del Potro, E., Deben, G., Abella, E., Bethencourt, C., Ortin, X., Bruntet, S., Ortega-Rivas, F., Novo, A., Lopez, R., Hernandez-Rivas, J.M., Sanz, M.A. & Feliu, E. (2007) Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. European Journal of Haematology, 78, 102-110.
16. Sive, J., Buck, G., Fielding, A., Lazarus, H.M., Litzow, M.R., Luger, S., Marks, D.I., McMillan, A., Moorman, A.V., Richards, S.M., Rowe, J.M., Tallman, M.S. & Goldstone, A.H. (2012) Outcomes in Older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. British Journal of Haematology, 157, 463-471.
17. Storring, J., Minden, M., Kao, S., Gupta, V., Schuh, A.C., Schimmer, A.D., Yee, K.W.Y., Kamel-Reid, S., Chang, H., Lipton, J.H., Messner, H.A., Xu, W. & Brandwein, J.M. (2009) Treatment of adults with BCR-ABL negative acute lymphoblastic leukemia with a modified paediatric regimen. British Journal of Haematology, 146, 76-85.
18. Taylor, P.R.A., Reid, M.M., Brown, N., Hamilt, P.J. & Proctor, S.J. (1992) Acute Lymphoblastic leukemia in patients aged 60 years and over: a population based study of incidence and outcome. Blood, 80, 1813-1817.
19. Thomas, D.A., Faderl, S., Cortes, J., O'Brien, S., Giles, F.J., Kornblau, S.M., Garcia-Manero, G., Keating, M.J., Andreeff, M., Jeha, S., Beran, M., Vertovsek, S., Pierce, S., Letvak, L., Salvado, A., Champlin, R., Talpaz, M. & Kantarjian, H. (2004) Treatment of Philadelphia chromosome positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood, 103, 4396-4407.
20. Topp, M.S., Kafer, P., Gokbuget, N., Goebeler, M., Klinger, M., Neumann, S., Horst, H.A., Roff, T., Viardot, A., Scmid, M., Stelljes, M., Schaich, M., Degenhard, E., Kohne-Vollanbd, R., Bruggermann, M., Ottmann, O., Pfeifer, H., Burmeister, T., Nagorsen, D., Schmidt, M., Lutterbuese, R., Reinhardt, C., Baeuerle, P.A., Kneba, M., Einsele, H., Riethmuller, G., Hoelzer, D., Zugmaier, G. & Bargou, R.C. (2011) Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. Journal of Clinical Oncology, 29, 2493-2498.
21. Vignetti, M., Fazi, P., Cimino, G., Martinelli, G., Di Raimondo, F., Ferrara, F., Meloni, G., Ambrosetti, A., Quarta, G., Pagano, L., Rege-Cambrin, G., Elia, L., Bertieri, R., Annino, L., Foa, R., Baccarani, M. & Mandelli, F. (2007) Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood, 109, 3676-3678.